EPCAM and hepatocellular carcinoma: In recent years, identification of rare populations (e.g. CD133, CD90 or EpCAM positive) from mainly AFP + HCC (E-HCC) cells and assessing their CSC features has been an approach in attempts to identify HCC stem cells16.